Rare diseases
Investigational molecules
Locations
Study of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
BelgiumStudy of Ruxolitinib Cream for Children and Adolescents Ages 6-17 with Moderate Atopic Dermatitis Who Did Not Respond Well to Standard Treatments
BelgiumStudy on the Effectiveness and Safety of Brensocatib for Patients with Chronic Rhinosinusitis Without Nasal Polyps
BelgiumStudy on the Effectiveness and Safety of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa
BelgiumStudy on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis
BelgiumStudy on the Effects of Itepekimab for Patients with Chronic Rhinosinusitis Without Nasal Polyps
BelgiumStudy on the Effectiveness and Safety of ESK-001 and Apremilast for Adults with Moderate to Severe Plaque Psoriasis
BelgiumStudy on the Effectiveness and Safety of Lanifibranor for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis Stages F2/F3
BelgiumStudy on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
BelgiumStudy on the Effects of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa
BelgiumStudy on the Effects of Amlitelimab for Adults with Non-Responsive Celiac Disease
BelgiumStudy on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
